Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Peptides & Oligos Logo (drop shadow)

PART OF NEXTGEN BIOMED 2026

24 - 25 March 2026 | QEII Centre, London, UK

Programme Summary

Delve into cutting-edge innovations in peptides and oligonucleotides discovery, therapeutics development & optimisation with key opinion leaders addressing novel computational tools, analytical strategies and sustainable chemistry & manufacturing practices.

Hear from past attendees of the NextGen Biomed 2025 conference

DAY TWO

Peptides & Oligonucleotides Keynote Address

ANDRES JÄSCHKE, Professor, Heidelberg University

Prof. Dr. Andres Jäschke is Professor of Pharmaceutical and Bioorganic Chemistry at Heidelberg University and Director at the Institute of Pharmacy & Molecular Biotechnology. He is internationally recognised for his pioneering work in RNA chemistry and epitranscriptomics. His honors include the Albrecht-Kossel Award of the German Chemical Society (2022), a prestigious ERC Advanced Grant (2020), and the BioFuture Award of the German Ministry of Research (1998).

2026 Highlights

Peptides

Spotlight what’s next in peptide therapeutics - cutting-edge chemistry, AI/ML-driven
analysis, peptide display and sequencing, with case studies spanning oncology,
regenerative medicine, and beyond.

Oligonucleotides

Stay ahead in oligonucleotide discovery & optimisation - hear from GSK, Sixfold Bio,
Roche, Novo Nordisk and others on computational tools, novel mechanisms, delivery
breakthroughs, and clinical progress. 

NextGen Biomed - What to Expect Exhibiting 3
NextGen Biomed - What to Expect Networking 1
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments
NGB + LSX Combined Logo-1

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things NextGen Biomed, direct to your inbox.

NGB Newsletter Icon-1

Peptides & Oligonucleotides Agenda at a Glance

DAY ONE - 25 MARCH

Track 6: Peptide Discovery & Green Chemistry
Track 7: Oligonucleotide Discovery & Green Chemistry   

DAY ONE - 26 MARCH


Track 5: Peptide Therapeutics & Development 
Track 6: Oligonucleotide Therapeutic Development & Optimisation    

NextGen Biomed Conference Brochure

Meet Our Expert Speakers

Peptides again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Hannah Bolt
Head of Peptide Discovery, Director,
AstraZeneca
Show More Speakers
Hide Speakers
Andrew Feilden
Senior Director Analytical Science,
Bicycle Therapeutics
Cécile Brocard
Head of Downstream Development,
Boehringer Ingelheim
Charles Johannes
Co-founder,
Peptide Drug Hunting Consortium
Daniel Fleischanderl
Director Upstream Development,
Boehringer Ingelheim
David Rodríguez
Principal Modelling Scientist,
Novo Nordisk
Elisabetta Bianchi
Director,
Curium Biopharma
Felix Wojcik
Principal Scientist,
Novo Nordisk
Fernando Albericio
Professor,
University of KwaZulu-Natal
John Wade
Professor and Head of Peptide & Protein Chemistry,
The Florey Institute
Kai Hilpert
Professor,
City St George's, University of London
Lukas Leder
Senior Principal Scientist,
Novartis
Mark Eccleston
CEO,
Valirx Plc
Michelle Barnard
Director of Research,
ValiRx
Mikhail Kuravsky
Principal Scientist,
UCB
Paul Reid
Chief Executive Officer,
Celtic Biotech
Ranganath Gopalakrishnan
Director,
AstraZeneca
Sunay Chankeshwara
Associate Principal Scientist,
Astrazeneca

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Register Now

Be part of the new wave of Biomed R&D innovation

Partner with us

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients